Medicamen Organics Limited IPO
NSE SMEListed On: Jun 28, 2024 at ₹ 137.85
₹ 136000 /4000 Shares
Check Allotment21 Jun, 2024
Open Date25 Jun, 2024
Close Date26 Jun, 2024
Allotment Date28 Jun, 2024
Listing DateIssue Price
₹32-34 per equity shareFace Value
₹10 Per Equity ShareListing at Group
NSE SMERegistrar
Kfin Technologies LimitedList Price
137.85Listing Date
2024-06-28Market Lot
4000 Shares (₹136,000/-)Lead Manager
GYR Capital Advisors Private LimitedIssue Size
3,100,000 shares(aggregating up to ₹10.54 Cr)Retail Portion
35%Subscription
993.64 times
The IPO of Medicamen Organics Limited is priced at ₹32-34 per equity share, which has a face value of ₹10 Per Equity Share each. The company shall list its equity shares on NSE SME. Kfin Technologies Limited is the registrar of the issue.
Medicamen Organics Limited IPO bid opening date is from Jun 21, 2024 and the bid closing date was Jun 25, 2024.
Medicamen Organics Limited IPO allotment result will be available on Jun 26, 2024. The tentative listing date for Medicamen Organics Limited is Jun 28, 2024.
The total issue size is 3,100,000 shares(aggregating up to ₹10.54 Cr).
Medicamen Organics Limited IPO Subscription Details
| As on | QIB / NII | Retail | Total |
|---|---|---|---|
| Shares Offered / Reserved | 584,000 / 440,000 | 1,028,000 | 2,052,000 |
| Day 1 - 21-06-24 06:00 PM | 1.01 / 37.20 x | 92.26 x | 54.49 x |
| Day 2 - 24-06-24 06:00 PM | 1.42 / 125.83 x | 348.14 x | 201.79 x |
| Day 3 - 25-06-24 06:00 PM | 173.03 / 1344.22 x | 1309.77 x | 993.64 x |
Medicamen Organics Limited Valuations
EPS Pre IPO
₹1.11/-EPS Post IPO
₹2.21/-P/E Pre IPO
30.53P/E Post IPO
15.41ROE
19.90%ROCE
14.50%Debt/Equity
0.83RoNW
15.83%PAT Margin
9.51Price to Book Value
2.39Medicamen Organics Limited Company Financials All values are in ₹ Lakh
| 31-Mar-24 | 31-Mar-23 | 31-Mar-22 | |
|---|---|---|---|
| Assets | 3,858.07 | 3,211.98 | 2,707.21 |
| Revenue | 2,528.96 | 2,296.24 | 2,118.67 |
| Profit After Tax | 240.41 | 95.78 | 9.23 |
| Net Worth | 1,518.40 | 851.71 | 755.92 |
| Reserves & Surplus | 658.40 | 251.71 | 155.92 |
| Total Borrowing | 1,265.65 | 1,179.50 | 1,024.57 |
About The Company
Medicamen Organics Limited was established in 1995 and engages in the development, manufacture, and marketing of pharmaceutical dosages, including generic dosages, in the form of tablets, capsules, oral liquids, ointments, gels, syrups, suspensions, and dry powders to the Government (State Governments and Central Governments) and private parties as a contract manufacturer/third-party manufacturer.
The company's product list includes 84 products and a wide range of drugs such as antibacterial, antidiarrheal, antifungal, antimalarial, antidiabetic, proton pump inhibitors, antihistamines, antihypertensive drugs, lipid preparations, antiparasitics, multivitamin preparations, multimineral and non-steroidal anti-inflammatory drugs (NSAIDS).
The company sells its products all over India as well as in African, CIS, and South East Asian countries such as Congo, Benin, Kameg, Togo, Senegal, Burkina Faso, Philippines, Myanmar, Mozambique, Togo, Burundi, Kyrgyzstan and Kenya through third-party distributors.
There are two WHO-GMP compliant manufacturing plants covering 21,536 Sq. Ft of Haridwar in Uttarakhand. By the date September 30, 2023, it entered a contract with manufacturing deals at domestic end through 38 companies and had the number of Merchant exporters totaling at 12 entities.
As of September 30, 2023, the total number of people employed by the company is 116.
Medicamen Organics Limited - Promoter(s)
Pre Issue Share Holding: 81.21%
Post Issue Share Holding: %
- Mr. Bal Kishan Gupta
Medicamen Organics Limited IPO - Issue Objectives
- Funding of expenses proposed to be incurred towards Product registration in the international markets
- Plant updation and increase in production capacity
- Funding working capital requirements of our Company
- General Corporate Purposes.
Other Details
Medicamen Organics Limited
10 Community Centre,, No 2 Ashok Vihar Phase II, New Delhi, Delhi, 110052Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: medicamen.ipo@kfintech.com
Medicamen Organics Limited IPO - FAQs
Ans. Medicamen Organics Limited IPO is a SME IPO. The issue is priced at ₹32-34 per equity share. The minimum order quantity is 4000 Shares. The IPO opens on Jun 21, 2024, and closes on Jun 25, 2024. Kfin Technologies Limited is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Ans. The Medicamen Organics Limited IPO opens on Jun 21, 2024 and closes on Jun 25, 2024.
Ans. The size of Medicamen Organics Limited IPO is 3,100,000 shares(aggregating up to ₹10.54 Cr).
Ans. The IPO price band is set between ₹32-34 per equity share.
Ans. To apply for Medicamen Organics Limited IPO IPO, follow the steps given below:
- - Open the IPO Ji App or Website
- - Find Medicamen Organics Limited IPO in the List of IPOs
- - Press "Apply" Button
- - Select Your Demat Account
- - Select Your Shares Quantity and Submit
- - Track Your IPO Status
Ans. The share allotment date of Medicamen Organics Limited IPO is Jun 26, 2024.
Ans. The Medicamen Organics Limited IPO will be listed on Jun 28, 2024.
Ans. Follow the steps to check the allotment status for Medicamen Organics Limited IPO here.
